Follow
A Bayesian time-to-event pharmacokinetic model for phase I dose-escalation trials with multiple schedules. (arXiv:2002.06204v1 [stat.ME]) http://arxiv.org/abs/2002.06204
A Bayesian time-to-event pharmacokinetic model for phase I dose-escalation trials with multiple schedules. (arXiv:2002.06204v1 [stat.ME]) http://arxiv.org/abs/2002.06204